ラクターゼ市場：原料の種類別・形状別・用途別・地域別（2026～2032年）

ラクターゼ市場の評価（2026～2032年）

ラクターゼ市場は、様々な産業用途における効率性、持続可能性、規制遵守の進化する基準を満たすための先端技術の採用により、大きな成長を遂げています。乳製品生産、食品加工、健康補助食品など幅広い用途で使用されるラクターゼは、多様な業務ニーズに革新的なソリューションを提供する上で不可欠です。2024年に2億9,146万米ドルと評価された市場は、2032年には約4億8,599万米ドルに達すると予測され、その力強い成長軌道が浮き彫りになっています。

自律遠隔操作システムへの需要が、ラクターゼ生産技術とシステム統合の進歩を後押ししています。これらの技術革新は、リアルタイムのデータ処理や精密な発酵など、自動化されたスマートシステムとのシームレスな統合を容易にし、それによって業務効率を高め、製品の成功を確実なものにしています。このような統合により、ラクターゼ市場は2026年から2032年にかけてCAGR6.60%を達成すると予測され、市場は強化されます。

ラクターゼ市場：定義／概要

ラクターゼは小腸で産生される酵素で、牛乳や乳製品に含まれる糖質である乳糖の消化に必要です。ラクターゼは乳糖をグルコースとガラクトースに変換し、体内に吸収されやすくします。ラクターゼの錠剤は、乳糖不耐症の治療によく使われます。この病気は、ラクターゼが十分でないために、乳製品を摂取すると胃痛を起こす病気です。

ラクターゼは様々な産業で幅広く応用されており、特に乳糖不耐症の人々のための無乳糖牛乳や乳製品の製造に利用されています。食品加工業では、ラクターゼは乳製品をベースにした成分の甘味と消化性を向上させます。製薬業界では、乳糖の消化を助ける栄養補助食品に利用され、乳糖不耐症の人々の消化器系全般の健康を改善します。

ラクターゼの将来は、技術改良と無乳糖商品への需要の高まりによって決まります。酵素合成とバイオテクノロジーにおける革新は、価格を下げながらラクターゼの効率を向上させると思われます。乳糖不耐症と健康上の懸念に関する知識の増加は、市場の成長を後押しします。さらに、食品加工や医薬品における新規用途の開発と、持続可能で植物由来の代替品へのシフトが相まって、ラクターゼ産業は強化されるでしょう。

乳糖不耐症の認知度向上はラクターゼ市場をどのように牽引するか？

乳糖不耐症に対する意識の高まりは、ラクターゼビジネスに大きな影響を与え、無乳糖製品に対する消費者の需要を促進しています。膨満感、ガス、下痢といった乳糖不耐症の症状を知る人が増えるにつれ、痛みを和らげるために乳糖不使用の代替品を求めるようになります。この需要は、乳製品メーカーが製造工程にラクターゼを組み込むことを促し、その結果、無乳糖製品の選択肢が広がり、ラクターゼ産業が活性化します。

乳糖不耐症は教育活動やヘルスケア活動で強調され、市場成長に大きく貢献しています。ヘルスケアの専門家や栄養士が乳糖不耐症とその治療について一般大衆を啓蒙するにつれて、消費者はより積極的に答えを探すようになります。このような知識の増加は、ラクターゼサプリメントや無乳糖乳製品の採用率の上昇につながり、市場の需要を煽り、ラクターゼ産業における技術革新や製品開拓を促進します。

意識の高まりは、食品加工におけるラクターゼの使用を奨励する規制や産業規範にも影響を与えます。政府や保健機関は、無乳糖製品の製造と表示を促進する規則を制定し、それによって消費者のアクセスを改善することができます。このような規制上の支援と消費者の需要とが相まって、ラクターゼ製造技術への投資と市場拡大が促進され、ラクターゼ市場の成長軌道と乳糖不耐症の人々の食生活の選択肢を増やす役割が強化されます。

耐性と副作用はラクターゼ市場の妨げになるか？

耐性や副作用はラクターゼビジネスに悪影響を及ぼす可能性がありますが、その影響は限定的です。ラクターゼサプリメントに対する耐性が時間の経過とともに形成され、その有効性が低下し、永久的な乳糖不耐症となる人もいるかもしれません。このため、ラクターゼ製品に対する顧客の信頼が低下し、消費者が別の食事方法を求めるようになり、市場の成長に影響を与える可能性があります。

さらに、ラクターゼ・ピルにはほとんど悪影響がないとはいえ、消費者によってはラクターゼ・ピルの使用を妨げる可能性もあります。アレルギー反応や胃の不快感は、敏感な人に起こりうる副作用です。これらの副作用に関する否定的な経験や懸念は、ラクターゼサプリメントの使用を思いとどまらせ、市場の成長を阻害し、全体的な需要を低下させる可能性があります。

耐性と副作用の商業的影響は、継続的な研究と製品革新によって軽減することができます。より効果的で忍容性の高いラクターゼ製剤を開発し、適切な使用法や潜在的な副作用に関する消費者情報を明示することで、使用経験と信頼を向上させることができます。これらの障害に積極的に取り組むことで、ラクターゼ市場は継続的に繁栄し、乳糖不耐症患者に効果的なソリューションを提供することができます。

目次

第1章 イントロダクション

• 市場の定義
• 市場区分
• 分析手法

第2章 エグゼクティブサマリー

• 主な分析結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 ラクターゼ市場：原料の種類別

• 微生物由来
• 動物由来

第5章 ラクターゼ市場：用途別

• 食品・飲料産業
• 医薬品
• 栄養補助食品

第6章 ラクターゼ市場：形状別

• 液体
• 粉末
• 錠剤

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• 新型コロナウイルス感染症 (COVID-19) の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Chr. Hansen Holding A/S（デンマーク）
• Kerry Group plc.（アイルランド）
• Koninklijke DSM N.V.（オランダ）
• Novozymes A/S（デンマーク）
• Merck KGaA（ドイツ）
• International Flavors & Fragrances Inc.（IFF）（米国）
• Amano Enzyme Inc.（日本）
• Advanced Enzyme Technologies（インド）
• Novact Corporation（米国）

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Lactase Market Valuation - 2026-2032

The lactase market is experiencing significant growth driven by the adoption of advanced technologies to meet evolving standards in efficiency, sustainability, and regulatory compliance across various industrial applications. With uses spanning dairy production, food processing, and health supplements, lactase is essential in delivering innovative solutions to a diverse range of operational needs. Valued at USD 291.46 Million in 2024, the market is projected to reach approximately USD 485.99 Million by 2032, highlighting its robust growth trajectory.

The demand for autonomous and remotely operated systems is propelling advancements in lactase production technologies and system integration. These innovations facilitate seamless integration with automated and smart systems such as real-time data processing and precision fermentation thereby enhancing operational efficiency and ensuring product success. This integration is set to strengthen the market with the lactase market anticipated to achieve a compound annual growth rate (CAGR) of 6.60% between 2026 and 2032.

Lactase Market - Definition/ Overview

Lactase is an enzyme produced in the small intestine that is necessary for the digestion of lactose, a sugar present in milk and dairy products. It converts lactose into glucose and galactose which are more readily absorbed by the body. Lactase pills are often used to treat lactose intolerance, a condition in which people lack adequate lactase causing stomach pain when they consume dairy products.

Lactase has a wide range of applications in a variety of industries most notably in the manufacturing of lactose-free milk and dairy products for lactose intolerant people. In the food processing business, lactase improves the sweetness and digestibility of dairy-based components. It is utilised in the pharmaceutical industry to create nutritional supplements that aid in lactose digestion, hence improving overall digestive health for people who are lactose intolerant.

The future of lactase is determined by technical improvements and rising demand for lactose-free goods. Innovations in enzyme synthesis and biotechnology will improve lactase efficiency while lowering prices. Increased knowledge of lactose intolerance and health concerns will boost market growth. Furthermore, the development of novel uses in food processing and medicines combined with a shift towards sustainable and plant-based alternatives will enhance the lactase industry.

How Raising Awareness of Lactose Intolerance Drive the Lactase Market?

Raising awareness of lactose intolerance has a huge impact on the lactase business driving consumer demand for lactose-free products. As more people become aware of lactose intolerance symptoms such as bloating, gas, and diarrhoea, they seek lactose-free alternatives to alleviate pain. This demand encourages dairy manufacturers to include lactase into their manufacturing processes resulting in a broader selection of lactose-free products and thus boosting the lactase industry.

Lactose intolerance is highlighted in educational efforts and healthcare activities which contribute significantly to market growth. As healthcare experts and nutritionists educate the public about lactose intolerance and its treatment, consumers become more proactive in looking for answers. This increased knowledge leads to higher adoption rates of lactase supplements and lactose-free dairy products fueling market demand and encouraging innovation and product development in the lactase industry.

Rising awareness also influences regulatory and industrial norms encouraging the use of lactase in food processing. Governments and health organisations may establish rules to promote the manufacturing and labelling of lactose-free products thereby improving consumer access. This regulatory support combined with consumer demand encourages investments in lactase manufacturing technologies and market expansion cementing the lactase market's growth trajectory and role in enhancing dietary options for lactose-intolerant people.

Will Tolerance and Side Effects Hamper the Lactase Market?

Tolerance and adverse effects could potentially harm the lactase business, however the impact could be limited. Some people may build resistance to lactase supplements over time diminishing their effectiveness and resulting in permanent lactose intolerance. This could lead to diminished customer confidence in lactase products prompting consumers to seek alternate dietary options and impacting market growth.

Furthermore, while lactase pills have few negative effects, they can prevent some consumers from using them. Allergic reactions or stomach discomfort are possible adverse effects in sensitive individuals. Negative experiences or concerns about these adverse effects can discourage people from using lactase supplements stifling market growth and lowering overall demand.

The commercial impact of tolerance and side effects can be reduced through ongoing research and product innovation. Creating more effective and well-tolerated lactase formulations together with explicit consumer information about proper usage and potential adverse effects can improve user experience and trust. By aggressively addressing these obstacles, the lactase market can continue to thrive and provide effective solutions for lactose-intolerant patients.

Category-Wise Acumens

Will Efficiency and Scalability Drive the Source type Segment?

Microbial dominate the market. In lactase manufacturing, microbial sources such as Aspergillus oryzae and Bacillus subtilis are used due to their efficiency and scalability. In terms of production yield and consistency, microbial-derived lactase outperforms animal-sourced enzymes. These microbes can be grown under regulated settings allowing fermentation operations to produce large amounts of lactase efficiently. Scalability is also improved by bioreactor technology which enables large-scale manufacturing to satisfy industrial demands effectively.

Furthermore, the efficiency of microbial sources is consistent with sustainability goals as fermentation procedures often need fewer resources and have a lower environmental impact than extracting enzymes from animals. This eco-friendly feature appeals to enterprises that want to reduce their environmental effect while retaining high production efficiency. As a result, the efficiency and scalability of microbial-derived lactase are expected to drive continued growth in this segment as manufacturers prioritize sustainable and cost-effective solutions for lactase production.

While animal-sourced lactase such as bovine or porcine lactase is still useful in some applications, its usage is frequently limited by availability, enzyme activity variability, and ethical considerations. These problems highlight the benefits of microbial sources in satisfying the increasing global demand for lactase in a variety of industrial applications including food and beverage, medicines, and nutritional supplements. Thus, the trend towards efficiency and scalability in lactase sourcing is projected to increase the market position of microbial-derived enzymes in the near term.

Will Widespread Use of Lactase in Production Drive the Application Segment?

Food & Beverages dominate the market. The broad usage of lactase in production is expected to create significant expansion across a variety of application categories. Lactase allows the food industry to produce lactose-free dairy products meeting the growing demand from lactose-intolerant consumers looking for alternatives that don't cause stomach pain. This use covers a wide range of products including milk, cheese, yoghurt, and ice cream boosting the market for lactase enzymes.

The pharmaceutical industry benefits from lactase's ability to create digestive aids and supplements that improve lactose digestion. The increased awareness and diagnosis of lactose intolerance drives demand for such medicinal applications adding to the total market growth of lactase enzymes.

The usage of lactase in industrial applications such as food processing and beverage production is constantly evolving. Lactase is used in the production of baked goods, infant formulae, and nutritional supplements, in addition to traditional dairy products. Its versatility in improving product quality and nutritional value by lowering lactose content or increasing digestibility highlights its critical significance in a wide range of industrial applications. As consumer preferences shift towards healthier and more easily digestible food options, the use of lactase is likely to grow, fueling further market expansion in the coming years.

Country/Region Wise Acumens

How High Consumer Awareness of Lactose Intolerance Drive the Lactase Market in North America Region?

North America dominates the lactase market. Consumer awareness of lactose intolerance is high in North America which helps to drive the lactase industry forward. As knowledge rises, more people notice symptoms like bloating and stomach pain after eating lactose-containing dairy products. This awareness encourages consumers to seek lactose-free alternatives raising demand for products treated with lactase enzymes which break down lactose into more readily digestible carbohydrates.

The prevalence of lactose intolerance across diverse ethnic groups in North America fuels the market's expansion. With a diverse population that includes many people of Asian, African, Hispanic, and Native American origin who frequently have higher rates of lactose intolerance, there is a considerable market for lactose-free dairy and related goods. This demographic diversity drives manufacturers to incorporate lactase into a wide range of foods and beverages to cater to diverse dietary preferences and needs.

North American healthcare practitioners and dietitians proactive attitude to educating the public about lactose intolerance and accessible treatments boosts market growth. This educational initiative not only raises consumer awareness but it also promotes acceptance and adoption of lactase-treated products as viable alternatives to regular dairy products. As a result, heightened consumer awareness, demographic considerations, and healthcare advocacy all contribute to the growth of the lactase market in North America.

Will Rising Lactose Intolerance Awareness Boost the Lactase Market in Asia-Pacific?

The Asia-Pacific region is the fastest-growing region in the lactase market. Rising lactose intolerance awareness is predicted to greatly increase the lactase market in Asia-Pacific. As knowledge grows, more people are recognising signs of lactose intolerance such as bloating and gastrointestinal discomfort after eating dairy products. This increased knowledge is driving demand for lactose-free alternatives prompting food and beverage makers to add lactase enzymes to their products to improve digestibility.

Furthermore, dairy consumption in the Asia-Pacific area has increased significantly as a result of economic expansion and urbanisation. As more people embrace Western diets that include dairy products, the number of lactose intolerance cases increases. This demographic shift opens up a significant market opportunity for lactase enzymes in the region as manufacturers attempt to meet the demand for lactose-free dairy products.

Healthcare professionals and dietitians in Asia-Pacific are progressively educating the public about lactose intolerance management and the benefits of lactase supplements. This educational effort improves customer awareness and acceptance of lactase-treated products accelerating industry expansion. As a result, the combination of increased knowledge, dietary changes, and healthcare advocacy is expected to propel the Asia-Pacific lactase market forward in the approaching years.

Competitive Landscape

The Lactase Market is a dynamic and competitive industry, marked by a diverse array of players striving to capture market share. These companies are actively engaged in efforts to solidify their presence by implementing strategic initiatives such as collaborations, mergers, acquisitions, and garnering political support. With a focus on innovation, these organizations are continuously enhancing their product offerings to meet the diverse needs of consumers across various regions.

Some prominent players in Lactase market include:

Chr. Hansen Holding A/S (Denmark)

Kerry Group plc. (Ireland)

Koninklijke DSM N.V. (Netherlands)

Novozymes A/S (Denmark)

Merck KGaA (Germany)

International Flavors & Fragrances Inc. (IFF) (US)

Amano Enzyme Inc. (Japan)

Advanced Enzyme Technologies (India)

Novact Corporation (US)

Latest Developments

Lactase Market Key Developments And Mergers

In June 2022, Koninklijke DSM N.V. (Netherlands) and Firmenich announced their merger. Firmenich is a big player in scent and flavours. This transaction will help the company expand its market position in the nutrition, health, and beauty categories. According to company sources, the merger will be finalised by 2024.

In February 2022, Kerry Group plc. (Ireland) bought c-LEcta, a German biotechnology innovation business that makes enzymes. c-LEcta specialises in precise enzyme fermentation and bioprocessing. This deal will allow Kerry to penetrate into the lactase enzymes market.

Lactase Market, By Category

• Source Type:
• Microbial
• Animal
• Application:
• Food and Beverages
• Pharmaceutical
• Dietary
• Form:
• Liquid
• Powder
• Tablet
• Region:
• North America
• Europe
• Asia Pacific
• Middle East and Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Lactase Market, By Source Type

• Microbial sources
• Animal sources

5. Lactase Market, By Application

• Food & beverage industry
• Pharmaceuticals
• Dietary supplements

6. Lactase Market, By Form

• Liquid
• Powder
• Tablets

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Chr. Hansen Holding A/S (Denmark)
• Kerry Group plc. (Ireland)
• Koninklijke DSM N.V. (Netherlands)
• Novozymes A/S (Denmark)
• Merck KGaA (Germany)
• International Flavors & Fragrances Inc. (IFF) (US)
• Amano Enzyme Inc. (Japan)
• Advanced Enzyme Technologies (India)
• Novact Corporation (US)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References